“To be clear...NP actually said this will prove efficacy? Not think it will or might?”


NP says lots of things. He did say in the Proactiv video that the M2M will show efficacy, but the question is efficacy for what? A primary or secondary endpoint? Safety? Another data point they discovered? We will find out next week and hopefully, based on EIND data, the efficacy will be in endpoints that will equate to a BP partner and an expedited phase 3/4.